Boxer Capital
Venture capital · Windermere, Florida, United States
Portfolio collected from the firm’s website, last checked Jun 28, 2026.Raises and exits come from each company’s own SEC and company records.
15Deep-tech portfolio3 active
11Portfolio exitsAcquired or listed
0Raises, 12 monthsLatest: Halda Therapeutics
74Co-investorsShare a portfolio company
Portfolio · 15 companies
| Company | Sector | Status | Latest raise | Raised |
|---|---|---|---|---|
| Mirador Therapeutics | Biotech | Active | Apr 3, 2024 | $413.0M |
| Prelude Therapeutics | Biotech | Active | Aug 28, 2020 | $97.0M |
| Zag Bio | Biotech | Active | — | — |
| Halda Therapeutics | Biotech | Acquired | Aug 12, 2024 | $197.9M |
| Relay Therapeutics | Biotech | Public | Jan 10, 2024 | $30.0M |
| Vividion Therapeutics | Biotech | Acquired | Mar 2, 2021 | $240.7M |
| Nuvation Bio | Biotech | Public | Oct 20, 2020 | $275.3M |
| Black Diamond Therapeutics | Biotech | Public | Dec 6, 2019 | $139.6M |
| Revolution Medicines | Biotech | Public | Nov 15, 2019 | $204.2M |
| Passage Bio | Biotech | Public | Sep 6, 2019 | $110.0M |
| SpringWorks Therapeutics | Biotech | Acquired | Sep 1, 2017 | $12.8M |
| Cytokinetics | Biotech | Public | — | — |
| Day One Biopharmaceuticals | Biotech | Acquired | — | — |
| Third Harmonic Bio | Biotech | Closed | — | — |
| Turning Point Therapeutics | Biotech | Acquired | — | — |
Peer ranks
Portfolio size#28
Portfolio exits#8
Raises, 12 months#88
Co-investors#6
Co-investors
- Frazier Healthcare PartnersVenture capital5 shared
- Perceptive Life SciencesVenture capital5 shared
- Biotechnology Value FundVenture capital4 shared
- Brookside CapitalVenture capital4 shared
- Deerfield Capital ManagementVenture capital4 shared
- EcoR1 CapitalVenture capital4 shared
- Perceptive AdvisorsVenture capital4 shared
- Third Rock VenturesVenture capital4 shared
- Bay City CapitalVenture capital3 shared
- Foresite CapitalVenture capital3 shared
Sectors
- Biotech15
Portfolios are collected from investors’ own websites and matched to tracked deep-tech companies by name; duplicate listings of the same firm are merged. Exits and raises come from each company’s own record: Form D through the latest filing.